the empiricist http://www.empiricist.ca/blog science, finance, and data Tue, 18 May 2010 04:11:10 +0000 http://backend.userland.com/rss092 en VIII. clinical trial transparency references http://www.empiricist.ca/blog/?p=101 VII. Conclusions: Towards Greater Clinical Trial Transparency http://www.empiricist.ca/blog/?p=98 VI. Bottom-Up Clinical Trial Transparency http://www.empiricist.ca/blog/?p=96 V. Legislative Strategies to Encourage Clinical Trial Transparency http://www.empiricist.ca/blog/?p=94 IV. Benefits & Costs of Transparency http://www.empiricist.ca/blog/?p=92 III. Clinical Trial Spin and Suppression http://www.empiricist.ca/blog/?p=88 II. Defining Clinical Trial Transparency http://www.empiricist.ca/blog/?p=85 Openness and Transparency in Clinical Trials http://www.empiricist.ca/blog/?p=77 Resveratrol: gushing about fountains of youth http://www.empiricist.ca/blog/?p=44 PatientsLikeMe: openness hits medicine http://www.empiricist.ca/blog/?p=39